Clik here to view.
AACR Special Conferences Gather Investigators Advancing Research on...
Based on estimates from the National Cancer Institute, in 2023, more than 110,000 cases of gynecologic cancers are expected to be diagnosed in the U.S., and approximately 34,000 people will die from...
View ArticleClik here to view.
FDA Approvals in Oncology: July-September 2023
With the approval of new anticancer therapeutics, more treatment options become available for patients. Some therapies are new to the market, while some may have already been approved for other...
View ArticleClik here to view.
Editors’ Picks: Highlights From the AACR Journals
As the temperatures start to drop and the leaves begin to change color, enjoy the latest selection of studies hand-picked by the editors of the 10 AACR journals. These include reports on a novel CAR...
View ArticleClik here to view.
25 Years of Trastuzumab: A Legacy of Innovation
The AACR Annual Meeting 2023, held April 14-19, commemorated several milestones, including the 25th anniversary of the approval of the blockbuster breast cancer drug trastuzumab (Herceptin)....
View ArticleClik here to view.
Party with a Purpose Honors Neuroblastoma Researchers
Neuroblastoma, a rare cancer that occurs primarily in children, is a scientific paradox, said pediatric oncologist John M. Maris, MD, of Children’s Hospital of Philadelphia (CHOP). “On one hand, a...
View ArticleClik here to view.
From the Bench: Creative Approaches in Cancer Research, Fall 2023
For our readers who enjoy learning about the newest tools and strategies in cancer research, the second installment of our series, “From the Bench,” is here. (Check out the inaugural post here.) This...
View ArticleClik here to view.
AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Keynotes Highlight...
Cancers are driven by unique genetic alterations, so what if we targeted these alterations to treat the cancer? It seems straightforward, but it’s easier said than done. The journey to treating cancer...
View ArticleClik here to view.
Taking a BiTE Out of Cancer
Our immune systems are equipped to recognize and destroy cancer cells—if they can find them, that is. And with tens of trillions of cells in the human body and the masterful hiding skills of cancers,...
View ArticleClik here to view.
Pancreatic Cancer: Research-driven Clinical Progress Examined at AACR Special...
With a five-year survival rate of only 12.5%, any progress toward new therapeutic approaches for pancreatic cancer is welcomed by patients and their families. November is Pancreatic Cancer Awareness...
View ArticleClik here to view.
Detecting Cancer with Body Fluids Other Than Blood
Ancient Greek physician Hippocrates considered the human body to be a system composed of four balanced fluids, or “humours.” The theory has long been supplanted, but contemporary oncology has brought...
View ArticleClik here to view.
Editors’ Picks: November Highlights from the AACR Journals
As the deep reds and yellows of fall leaves give way to twinkling holiday lights, we welcome the new season with a fresh selection of Editors’ Picks from the 10 AACR journals. This month’s chosen...
View ArticleClik here to view.
The Five ‘W’s’ (and ‘H’) of SABCS 2023
Each December, an impressive cohort of breast cancer researchers gathers for the San Antonio Breast Cancer Symposium (SABCS), one of the largest breast cancer meetings in the world. Nestled between...
View ArticleClik here to view.
SABCS 2023: POSITIVE Results for Breast Cancer Patients Wanting to Conceive
A breast cancer diagnosis can pose innumerable challenges, and with the average age at diagnosis dropping, the impact of treatment on fertility can present yet another heartache. For a woman who...
View ArticleClik here to view.
SABCS 2023: Some Patients May Safely Skip Radiation
Studies featured at this year’s San Antonio Breast Cancer Symposium (SABCS) suggest that—in some situations—adjuvant radiotherapy may not be needed. The results could allow some patients with breast...
View ArticleClik here to view.
SABCS 2023: Defining and Demystifying Inflammatory Breast Cancer
In 1994, at the age of 40, Ginny Mason, RN, began noticing some concerning differences in the size and color of one of her breasts, accompanied by new shooting pains. The radiologist who reviewed her...
View ArticleClik here to view.
SABCS 2023: As Conference Ends, Experts Look to the Future
“What will you do Monday morning?” was the question posed by the final session on the final full day of the 2023 San Antonio Breast Cancer Symposium (SABCS), held Tuesday, December 5 to Saturday,...
View ArticleClik here to view.
Experts Forecast 2024, Part 1: Advances in Cancer Vaccines
2024 is here, and there is so much on the year’s agenda—a total solar eclipse over parts of North America; the Summer Olympics in Paris; the first crewed lunar mission in over 50 years; and major...
View ArticleClik here to view.
Experts Forecast 2024, Part 3: Precision Medicine for Cancer Treatment
In anticipation of the new year, we asked four experts to predict the advances we might see in 2024 in their respective fields. In part 3 of this four-part series, we share thoughts from AACR...
View ArticleClik here to view.
Experts Forecast 2024, Part 4: Cutting-edge Tech for Oncology Drug Discovery
In anticipation of the new year, we asked four experts to predict the advances we might see in 2024 in their respective fields. In part 4 of this four-part series, we share thoughts from Paul Workman,...
View ArticleClik here to view.
Finding the Right Targets to Treat Biliary Tract Cancers
Biliary tract cancers (BTCs) have not always been easy to understand. That has been true for both patients—who might not even know about the existence of these thin tubes that transport bile from the...
View Article